Loading...
Loading...
AXDX| Name | Value |
|---|---|
| Revenues | 3.0M |
| Cost of Revenue | 2.3M |
| Gross Profit | 0.7M |
| Operating Expense | 14.8M |
| Operating I/L | -14.2M |
| Other Income/Expense | -0.7M |
| Interest Income | 0.4M |
| Pretax | -14.9M |
| Income Tax Expense | -0.1M |
| Net Income/Loss | -14.8M |
Accelerate Diagnostics, Inc. is an in vitro diagnostics company that provides solutions for the diagnosis of serious infections. The company's main product is the Accelerate Pheno system, an in vitro diagnostic platform that identifies and tests antibiotic susceptibility of pathogens associated with serious or health care-associated infections. This includes gram-positive and gram-negative organisms. The company also offers the Accelerate PhenoTest, a test kit for the system, which provides identification and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia. These products address life-threatening conditions with high morbidity and mortality risk, generating revenue for the company.
